Background/AimsAutoimmune gastritis (AIG) is a corpus-dominant atrophic gastritis in which patients are positive for antiparietal cell antibody (APCA) and/or anti-intrinsic factor antibody. The risk of developing gastric cancer in patients with AIG remains unclear, and reliable frequency data of AIG in patients with gastric cancer are lacking.MethodsWe included 624 Korean patients with gastric tumors (612 gastric cancers and 12 neuroendocrine tumors) who had APCA results and were available for AIG evaluation. In patients with positive APCA results, endoscopy and histology findings were reviewed to diagnose AIG.ResultsOf the 624 patients, 37 (5.9%) tested positive for APCA, and ultimately, 11 (1.8%) met the diagnostic criteria for AIG (5 both endoscopy and histology findings, 4 endoscopy-only findings, 2 histology-only findings). The frequency of AIG in patients with gastric cancer was 1.3% (8/612), and that in patients with neuroendocrine tumors was 25.0% (3/12). Of the 11 patients with AIG, serum Helicobacter pylori antibody was positive in six patients (54.5%), all of whom had gastric cancer. Histologically, three patients showed pure AIG, four patients exhibited concurrent AIG and H. pylori gastritis, and the findings for four were indefinite for AIG. The pepsinogen (PG) I levels and PG I/II ratio were significantly lower in patients with gastric cancer with AIG than in patients with gastric cancer without AIG (p=0.042 and p=0.016, respectively).ConclusionsThe frequency of AIG in gastric cancer patients was very low compared to that in patients with neuroendocrine tumors. Rather, concurrent AIG and H. pylori gastritis was common in patients with AIG with gastric cancer.

2024-06-25·Cureus

Coexistence of Guillain-Barré Syndrome and Subacute Combined Degeneration of the Spinal Cord Due to Autoimmune Gastritis: A Case Report and Literature Review

Article

作者: Cai, Moushan ; Xiang, Huiyao

Guillain-Barré syndrome (GBS) and autoimmune gastritis (AIG) are both autoimmune diseases (ADs) that have a low prevalence in China. Both conditions involve the immune system mistakenly attacking the body's own tissues. GBS primarily affects the peripheral nervous system, leading to muscle weakness and paralysis, while AIG targets the stomach lining, causing inflammation and reduced absorption of vital nutrients. Subacute combined degeneration (SCD) of the spinal cord is the most common neurological manifestation of vitamin B12 deficiency. As of yet, there have been no reported cases of patients with GBS and complications of AIG including SCD. We report a case of a 54-year-old male patient who had been experiencing progressive numbness and weakness in his extremities, burning and tingling sensations, a cotton-stepping sensation, and difficulty walking for three weeks. He was admitted to the hospital and underwent an extensive medical workup. Magnetic resonance imaging (MRI) of the cervical spine cord showed abnormal spinal cord signal intensity consistent with typical manifestations of vitamin B12 deficiency. Gastric endoscopy revealed local atrophy of the gastric corpus, and gastric tissue biopsy indicated atrophic gastritis with intestinal metaplasia, consistent with a diagnosis of AIG. Lumbar puncture of cerebrospinal fluid (CSF) results showed albumincytological dissociation, further confirming the diagnosis of GBS. He was treated with intravenous immunoglobulin and methylcobalamin therapy for these conditions and showed significant clinical improvement upon discharge.

1993-09-01·Journal of Cellular Physiology2区 · 生物学

Expression of transforming growth factor α antisense mRNA inhibits the estrogen‐induced production of TGFα and estrogen‐induced proliferation of estrogen‐responsive human breast cancer cells

2区 · 生物学

Article

作者: N. Normanno ; T. Saeki ; M. B. Martin ; D. S. Salomon ; N. J. Kenney ; M. Gottardis ; F. Ciardiello ; N. Kim ; P. Garcia-Morales ; M. L. Cutler ; A. Day

AbstractTo ascertain if 17β‐estradiol (E2)‐induced proliferation could be attenuated by blocking the expression of endogenous transforming growth factor α (TGFα), estrogen receptor (ER)‐positive, estrogen‐responsive MCF‐7 or ZR‐75‐1 cells and ER‐negative, estrogen‐nonresponsive MDA‐MB‐468 or HS‐578T cells were infected with a recombinant amphotropic, replication‐defective retroviral expression vector containing a 435 base pair (bp) Apa1‐Eco R1 coding fragment of the human TGFα cDNA oriented in the 3′ to 5′ direction and under the transcriptional control of an internal heavy metal‐inducible mouse metallothionein (MT‐1) promoter and containing the neomycin (neo) resistance gene. E2‐stimulated expression of endogenous TGFα mRNA was inhibited by 4–5‐fold, and the production of TGFα protein was inhibited by 50–80% when M‐1 mass‐infected MCF‐7 or MZ‐1 mass‐infected ZR‐75‐1 cells were treated with 0.75‐1 μM CdCl2, whereas in comparably treated parental MCF–7 or ZR‐75‐1 cells there was no significant effect upon these parameters. E2‐stimulated anchorage‐dependent growth (ADG) and anchorage‐independent growth (AIG) of the M‐1 or MZ‐1 cells was inhibited by 60–90% following CdCl2 treatment. In contrast, neither the ADG nor AIG of the parental noninfected MCF‐7 or ZR‐75‐1 cells that were maintained in the absence or presence of E2 was affected by comparable concentrations of CdCl2. The ADG and AIG of TGFα antisense MD‐1 mass‐infected MDA‐MB‐468 cells that express high levels of endogenous TGFα mRNA were also inhibited by 1 μM CdCl2, whereas the ADG and AIG of MH‐1 mass‐infected HS‐578T cells, a TGFα‐negative cell line, were unaffected by CdCl2 treatment. These results suggest that TGFα may be one important autocrine intermediary in regulating estrogen‐induced cell proliferation. © 1993 Wiley‐Liss, Inc.

100 项与 AIG-Immune1 相关的药物交易

登录后查看更多信息

研发状态

10 条进展最快的记录,

后查看更多信息

适应症	最高研发状态	国家/地区	公司	日期
自身免疫性疾病	药物发现	韩国	Lmito Therapeutics Co. Ltd.	2024-05-15
自身免疫性疾病	药物发现	韩国	Aigen Sciences, Inc.初创企业	2024-05-15